Remodeling and fibrosis in chronic eosinophil inflammation

Digestive Diseases

Volumn 32, Issue 1-2, 2014, Pages 15-21

  Aceves, Seema S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Eosinophilic esophagitis; Eosinophils; Fibrosis; Natural history; Remodeling

Indexed keywords

ANGIOGENIN; BUDESONIDE; COLLAGEN; CORTICOSTEROID; CYTOKERATIN; EOTAXIN 3; FIBROBLAST GROWTH FACTOR 9; FIBRONECTIN; FLUTICASONE; FOOD ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 9; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR GATA 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VIMENTIN;

ANGIOGENESIS; CELL HYPERPLASIA; CHRONIC EOSINOPHILIC INFLAMMATION; CORTICOSTEROID THERAPY; DISEASE COURSE; DYSPHAGIA; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGUS STENOSIS; FIBROSIS; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; HYPEREOSINOPHILIC SYNDROME; INFLAMMATORY CELL; MAST CELL; MOLECULAR PATHOLOGY; MUSCLE HYPERTROPHY; PRIORITY JOURNAL; REVIEW; SATIETY; SMOOTH MUSCLE CONTRACTION; WEIGHT REDUCTION; ARTICLE; DISEASE ASSOCIATION; EOSINOPHILIC GASTROINTESTINAL DISORDER; NONHUMAN; QUALITY OF LIFE;

ANIMALS; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; ESOPHAGUS; FIBROSIS; HUMANS; INFLAMMATION;

EID: 84896132453     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000357004     Document Type: Review

References (53)

1. Podjasek JC, Butterfield JH: Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature. Leuk Res 2013; 37: 392-395.
2. Broide DH: Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol 2008; 121: 560-570, quiz 571-572. (Pubitemid 351323873)
3. Malmstrom K, Pelkonen AS, Makela MJ: Remodeling, inflammation and airway responsiveness in early childhood asthma. Curr Opin Allergy Clin Immunol 2013; 13: 203-210.
4. Klion A: Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu Rev Med 2009; 60: 293-306.
5. Aceves SS, Ackerman SJ: Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am 2009; 29: 197-211, xiii-xiv.
6. Aceves SS: Tissue remodeling in patients with eosinophilic esophagitis: what lies beneath the surface? J Allergy Clin Immunol 2011; 128: 1047-1049.
7. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, et al: Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20.e26, quiz 21-22.
8. Cheng E, Souza RF, Spechler SJ: Tissue remodeling in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 2012; 303:G1175-G1187.
9. Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU: Natural history of primary eosinophilic esophagitis: a followup of 30 adult patients for up to 11.5 years. Gastroenterology 2003; 125: 1660-1669. (Pubitemid 37500430)
10. Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, Schoepfer A, Simon HU: Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011; 9: 400-409.e1.
11. Fox VL, Nurko S, Teitelbaum JE, Badizadegan K, Furuta GT: High-resolution EUS in children with eosinophilic 'allergic' esophagitis. Gastrointest Endosc 2003; 57: 30-36. (Pubitemid 36236795)
12. Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH: Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007; 119: 206-212. (Pubitemid 46037819)
13. Chehade M, Sampson HA, Morotti RA, Magid MS: Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2007; 45: 319-328. (Pubitemid 47415083)
14. Niranjan R, Mavi P, Rayapudi M, Dynda S, Mishra A: Pathogenic role of mast cells in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 2013; 304:G1087-G1094.
15. Aceves SS, Chen D, Newbury RO, Dohil R, Bastian JF, Broide DH: Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol 2010; 126: 1198-1204.e4.
16. Lucendo AJ, Arias A, De Rezende LC, Yague-Compadre JL, Mota-Huertas T, Gonzalez-Castillo S, Cuesta RA, Tenias JM, Bellon T: Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. J Allergy Clin Immunol 2011; 128: 1037-1046.
17. Mavi P, Rajavelu P, Rayapudi M, Paul RJ, Mishra A: Esophageal functional impairments in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 2012; 302:G1347-G1355.
18. Mishra A, Wang M, Pemmaraju VR, Collins MH, Fulkerson PC, Abonia JP, Blanchard C, Putnam PE, Rothenberg ME: Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 2008; 134: 204-214. (Pubitemid 350309313)
19. Kagalwalla AF, Akhtar N, Woodruff SA, Rea BA, Masterson JC, Mukkada V, Parashette KR, Du J, Fillon S, Protheroe CA, et al: Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol 2012; 129: 1387-1396.e7.
20. Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, Bastian JF, Broide DH: Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65: 109-116.
21. Lieberman JA, Morotti RA, Konstantinou GN, Yershov O, Chehade M: Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort. Allergy 2012; 67: 1299-1307.
22. Abu-Sultaneh SM, Durst P, Maynard V, Elitsur Y: Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis. Dig Dis Sci 2011; 56: 97-102.
23. Assa'ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL, Buckmeier BK, Bullock JZ, Collier AR, Konikoff MR, et al: Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 2007; 119: 731-738. (Pubitemid 46335818)
24. Mulder DJ, Pacheco I, Hurlbut DJ, Mak N, Furuta GT, MacLeod RJ, Justinich CJ: FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis. Gut 2009; 58: 166-173.
25. Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C, Beglinger C, Smith DA, Patel J, Byrne M, et al: Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 2010; 59: 21-30.
26. Blanchard C, Stucke EM, Burwinkel K, Caldwell JM, Collins MH, Ahrens A, Buckmeier BK, Jameson SC, Greenberg A, Kaul A, et al: Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol 2010; 184: 4033-4041.
27. Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX, Collins MH, Putnam PE, Wells SI, Rothenberg ME: IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007; 120: 1292-1300. (Pubitemid 350225686)
28. Zuo L, Fulkerson PC, Finkelman FD, Mingler M, Fischetti CA, Blanchard C, Rothenberg ME: IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol 2010; 185: 660-669.
29. Blanchard C, Mingler MK, McBride M, Putnam PE, Collins MH, Chang G, Stringer K, Abonia JP, Molkentin JD, Rothenberg ME: Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol 2008; 1: 289-296. (Pubitemid 351850535)
30. Blanchard C, Mishra A, Saito-Akei H, Monk P, Anderson I, Rothenberg ME: Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy 2005; 35: 1096-1103. (Pubitemid 41603145)
31. Abonia JP, Blanchard C, Butz BB, Rainey HF, Collins MH, Stringer K, Putnam PE, Rothenberg ME: Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol 2010; 126: 140-149.
32. Dellon ES, Chen X, Miller CR, Fritchie KJ, Rubinas TC, Woosley JT, Shaheen NJ: Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol 2011; 106: 264-271.
33. Assa'ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HG, Aceves SS: An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology 2011; 141: 1593-1604.
34. Otani IM, Anilkumar AA, Newbury RO, Bhagat M, Beppu LY, Dohil R, Broide DH, Aceves SS: Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol 2013; 131: 1576-1582.
35. Akhurst RJ, Hata A: Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov 2012; 11: 790-811.
36. Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H, Bussmann C, Beglinger C, Schoepfer A, Simon HU: Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010; 139: 1526-1537.
37. Noti M, Wojno ED, Kim BS, Siracusa MC, Giacomin PR, Nair MG, Benitez AJ, Ruymann KR, Muir AB, Hill DA, et al: Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med 2013; 19: 1005-1013.
38. Persad R, Huynh HQ, Hao L, Ha JR, Sergi C, Srivastava R, Persad S: Angiogenic remodeling in pediatric EoE is associated with increased levels of VEGF-A, angiogenin, IL-8, and activation of the TNFα-NFκB pathway. J Pediatr Gastroenterol Nutr 2012; 55: 251-260.
39. Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE: Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology 2011; 140: 82-90.
40. Straumann A, Bussmann C, Zuber M, Vannini S, Simon HU, Schoepfer A: Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol 2008; 6: 598-600.
41. Franciosi JP, Hommel KA, Bendo CB, King EC, Collins MH, Eby MD, Marsolo K, Abonia JP, von Tiehl KF, Putnam PE, et al: PedsQL eosinophilic esophagitis module: feasibility, reliability, and validity. J Pediatr Gastroenterol Nutr 2013; 57: 57-66.
42. Franciosi JP, Hommel KA, Greenberg AB, Debrosse CW, Greenler AJ, Abonia JP, Rothenberg ME, Varni JW: Development of the Pediatric Quality of Life Inventory TM Eosinophilic Esophagitis module items: qualitative methods. BMC Gastroenterol 2012; 12: 135.
43. Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I: Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 2012; 142: 1451-1459. e1.
44. Harris RF, Menard-Katcher C, Atkins D, Furuta GT, Klinnert MD: Psychosocial dysfunction in children and adolescents with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2013; 57: 500-505.
45. Schoepfer AM, Safroneeva E, Bussmann C, Kuchen T, Portmann S, Simon HU, Straumann A: Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation, in a time-dependent manner. Gastroenterology 2013, E-pub ahead of print.
46. Li-Kim-Moy JP, Tobias V, Day AS, Leach S, Lemberg DA: Esophageal subepithelial fibrosis and hyalinization are features of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2011; 52: 147-153.
47. Parfitt JR, Gregor JC, Suskin NG, Jawa HA, Driman DK: Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol 2006; 19: 90-96. (Pubitemid 43250983)
48. Aceves SS, Newbury RO, Dohil MA, Bastian JF, Dohil R: A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. Ann Allergy Asthma Immunol 2009; 103: 401-406.
49. Nicodeme F, Hirano I, Chen J, Robinson K, Lin Z, Xiao Y, Gonsalves N, Kwasny MJ, Kahrilas PJ, Pandolfino JE: Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2013; 11: 1101-1107.
50. Korsapati H, Babaei A, Bhargava V, Dohil R, Quin A, Mittal RK: Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis. Gut 2009; 58: 1056-1062.
51. Nurko S, Rosen R, Furuta GT: Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Am J Gastroenterol 2009; 104: 3050-3057.
52. Nicholson AG, Li D, Pastorino U, Goldstraw P, Jeffery PK: Full thickness eosinophilia in oesophageal leiomyomatosis and idiopathic eosinophilic oesophagitis. A common allergic inflammatory profile? J Pathol 1997; 183: 233-236. (Pubitemid 27436030)
53. Lee J, Huprich J, Kujath C, Ravi K, Enders F, Smyrk TC, Katzka DA, Talley NJ, Alexander JA: Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol 2012; 10: 481-486.